Jacqueline Grunefelder
Nurse Practitioner · Linton, NDNPI 1790701241
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Boehringer Ingelheim at 24.7% of the total. Reporting peaked in 2022 at $413 and has fallen 64.3% since, to $147 in 2025.
Across 81 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$371
- Lilly USA, LLC$249
- AbbVie$168
- Pfizer$108
- Amgen$104
- Sanofi-aventis U.S. LLC$96
- plus $407 from 13 others
What the payments were for
- Food & beverage$1,502100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 20 | $371 |
| Lilly USA, LLC | 14 | $249 |
| AbbVie | 6 | $168 |
| Pfizer | 7 | $108 |
| Amgen | 7 | $104 |
| Sanofi-aventis U.S. LLC | 6 | $96 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Myriad Women's Health, Inc. | 1 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Irhythm Technologies, Inc. | 2 | $40 |
| Exact Sciences | 2 | $33 |
| Bayer | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Eisai Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $18 |
| Novartis | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| AstraZeneca | 1 | $13 |
How this compares
$1,502 in reported general payments places this provider in the 85th percentile of 455 nurse practitioner providers in North Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 129 | $114,617 |
| EliquisApixaban | 152 | $90,610 |
| OzempicSemaglutide | 44 | $81,631 |
| Tresiba Flextouch U-200Insulin Degludec | 38 | $34,105 |
| RybelsusSemaglutide | 23 | $33,756 |
| MounjaroTirzepatide | 29 | $31,271 |
| TrulicityDulaglutide | 25 | $31,035 |
| MyrbetriqMirabegron | 36 | $25,720 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 39 | $24,704 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 19 | $21,690 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $13,408 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $12,428 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $12,149 |
| Novolog FlexpenInsulin Aspart | 35 | $9,479 |
| FarxigaDapagliflozin Propanediol | 14 | $7,193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $371 | $114,617129 claims |
| PfizerEliquis | $108 | $90,610152 claims |
| Lilly USA, LLCMounjaro, Trulicity | $249 | $62,30654 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $96 | $21,69019 claims |
| AstraZenecaFarxiga | $13 | $7,19314 claims |
| AbbVieSynthroid | $168 | $1,04015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 455 nurse practitioner providers in North Dakota.
Other nurse practitioner in Linton
- Emily GreensteinFargo$271K
- Sarah MatchaFargo$17K
- Jana SuderFargo$16K
- Lisa ClairmontBismarck$15K
- Jenna KelschMinot$9K
- McKinzie NussBismarck$7K
- Nicole MorganGrand Forks$7K
- Paula MochBismarck$5K
- Trina KaiserBismarck$5K
- Cassie HoltBismarck$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.